Dr. Gallagher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Irving Street
C-2149
Washington, DC 20010Phone+1 202-877-8112Fax+1 202-877-8110- Is this information wrong?
Education & Training
- National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2004
- National Capital ConsortiumResidency, Internal Medicine, 1997
- Georgetown University School of MedicineClass of 1994
- University of Notre DameB.S., 1990
Certifications & Licensure
- MD State Medical License 2012 - 2026
- DC State Medical License 2014 - 2024
- VA State Medical License 1995 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Georgetown University School of Medicine, 1993
Publications & Presentations
PubMed
- 15 citationsDelay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast ...Christopher Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guerin
Breast Cancer Research and Treatment. 2016-04-23 - 7 citationsPALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative adva...Filipa Lynce, Mervat Saleh, Ayesha N. Shajahan-Haq, Christopher Gallagher, Asma Dilawari
Contemporary Clinical Trials Communications. 2018-05-07 - 93 citationsProspective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt studyFilipa Lynce, Ana Barac, X. Geng, Chau T. Dang, Anthony F. Yu
Breast Cancer Research and Treatment. 2019-03-09
Journal Articles
- Survival in Patients with HER2-POSITIVE Early Stage Breast Cancer Treated with Adjuvant Trastuzumab in Clinical PracticeGallagher CM, More K, Masaquel, et al, SpingerPlus, 1/1/2016
- Delay in Trastuzumab Initiation Leads to Decreased Overall Survival in Patients with HER2+ Early Stage Breast CancerGallagher CM, More K, Masaquel A , et. Al, Breast Cancer Res Treat, 1/1/2016
- Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States MilitaryBrzezniak C, Satran-Hoang S, Goetz H, Reyes C, Gunuganti A, Gallagher C, Carter C, J Gen Intern Med, 1/1/2015
- Join now to see all
Abstracts/Posters
- Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy:...Khoury K, Isaacs C, Gatti-Mays ME, Donahue RN, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain SM, Pohlmann PR, Lynce F, San Antonio Breast Cancer Symposium, 1/7/2018
- SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular functionLynce F, Barac A, Geng X, Dang C, Yu A, Smith KL, Gallagher C, Pohlmann PR, Nunes M, Herbolsheimer P, Warren R, Srichai B, Hofmeyer M, Cunningham A, Timothee P, Asch F..., J Clin Oncol, 1/1/2018
- Increasing participation in research - breast cancer (Inspire-BrC)Swain S, Robinson BN, Newman AF, Tefera E, Herbolsheimer P, Nunes R, Gallagher C, Randolph-Jackson P, Omogbehin A, Dilawari A, Pohlmann P, Mohebtash M, Ottaviano Y, Mo..., San Antonio Breast Cancer Symposium, 1/5/2016
- Join now to see all
Lectures
- Update on Adjuvant Therapy for Early Stage Breast CancerWalter Reed National Military Medical Center - 1/1/2012
- Adopting New Standards of Cancer Care: Challenges and OpportunitiesLapidus Cancer Institute, Sinai Hospital of Baltimore, Baltimore, MD - 1/1/2011
- One Step Forward, One Step Back: The Utility of Pharmacogenomics and Bisphosphonates in Early Stage Breast CancerFarmington, PA - 1/1/2011
- Join now to see all
Other
- ASCO/CAP Guidelines To Determine ER Status May Need RehaulGallagher CM, General Surgery News
http://www.generalsurgerynews.com/ViewArticle.aspx?d=In+the+News&d_id=69&i=June+2012&i_id=857&a_id=21046
1/1/2012 - A Sea Change for Military Medicine: Walter Reed Joins Navy Medical Center in BethesdaGallagher CM, U.S. Medicine
http://www.usmedicine.com/articles/a-sea-change-for-military-medicine-walter-reed-joins-navy-medical-center-in-bethesda.html?page=2
1/1/2011
Press Mentions
- MedStar Health Leads $5 Million CDC- Funded Project Aimed at Improving Cancer Survivorship and Reduce Patient InequitiesOctober 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: